Literature DB >> 24429307

Reasons for defaulting from drug-resistant tuberculosis treatment in Armenia: a quantitative and qualitative study.

E Sanchez-Padilla1, C Marquer1, S Kalon2, S Qayyum2, A Hayrapetyan3, F Varaine2, M Bastard1, M Bonnet1.   

Abstract

SETTING: Armenia, a country with a high prevalence of drug-resistant tuberculosis (DR-TB).
OBJECTIVE: To identify factors related to default from DR-TB treatment in Yerevan.
DESIGN: Using a retrospective cohort design, we compared defaulters with patients who were cured, completed or failed treatment. Patients who initiated DR-TB treatment from 2005 to 2011 were included in the study. A qualitative survey was conducted including semi-structured interviews with defaulters and focus group discussions with care providers.
RESULTS: Of 381 patients, 193 had achieved treatment success, 24 had died, 51 had failed treatment and 97 had defaulted. The number of drugs to which the patient was resistant at admission (aRR 1.16, 95%CI 1.05-1.27), the rate of treatment interruption based on patient's decision (aRR 1.03, 95%CI 1.02-1.05), the rate of side effects (aRR 1.18, 95%CI 1.09-1.27), and absence of culture conversion during the intensive phase (aRR 0.47, 95%CI 0.31-0.71) were independently associated with default from treatment. In the qualitative study, poor treatment tolerance, a perception that treatment was inefficient, lack of information, incorrect perception of being cured, working factors and behavioural problems were factors related to treatment default.
CONCLUSION: In addition to economic reasons, poor tolerance of and poor response to treatment were the main factors associated with treatment default.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24429307     DOI: 10.5588/ijtld.13.0369

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  15 in total

1.  Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.

Authors:  Thomas W McNally; Gilles de Wildt; Graciela Meza; Connie M D Wiskin
Journal:  BMC Health Serv Res       Date:  2019-08-22       Impact factor: 2.655

2.  Risk factors for poor engagement in drug-resistant TB care in South Africa: a systematic review.

Authors:  K C McNabb; A Bergman; J E Farley
Journal:  Public Health Action       Date:  2021-09-21

3.  Loss-To-Follow-Up on Multidrug Resistant Tuberculosis Treatment in Gujarat, India: The WHEN and WHO of It.

Authors:  Kalpita S Shringarpure; Petros Isaakidis; Karuna D Sagili; R K Baxi
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

4.  Loss from treatment for drug resistant tuberculosis: risk factors and patient outcomes in a community-based program in Khayelitsha, South Africa.

Authors:  Sizulu Moyo; Helen S Cox; Jennifer Hughes; Johnny Daniels; Leigh Synman; Virginia De Azevedo; Amir Shroufi; Vivian Cox; Gilles van Cutsem
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

5.  Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.

Authors:  Amber Kunkel; Frank G Cobelens; Ted Cohen
Journal:  PLoS Med       Date:  2016-10-11       Impact factor: 11.069

6.  Risk factors associated with loss to follow-up from tuberculosis treatment in Tajikistan: a case-control study.

Authors:  Jessica Wohlleben; Mavluda Makhmudova; Firuza Saidova; Shahnoza Azamova; Christina Mergenthaler; Suzanne Verver
Journal:  BMC Infect Dis       Date:  2017-08-04       Impact factor: 3.090

7.  Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.

Authors:  Mathieu Bastard; Elisabeth Sanchez-Padilla; Philipp du Cros; Atadjan Karimovich Khamraev; Nargiza Parpieva; Mirzagaleg Tillyashaykov; Armen Hayrapetyan; Kamene Kimenye; Shazina Khurkhumal; Themba Dlamini; Santiago Fadul Perez; Alex Telnov; Cathy Hewison; Francis Varaine; Maryline Bonnet
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

8.  Predictors of Default from Treatment for Tuberculosis: a Single Center Case-Control Study in Korea.

Authors:  Cheol-Kyu Park; Hong-Joon Shin; Yu-Il Kim; Sung-Chul Lim; Jeong-Sun Yoon; Young-Su Kim; Jung-Chul Kim; Yong-Soo Kwon
Journal:  J Korean Med Sci       Date:  2016-01-13       Impact factor: 2.153

9.  Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Authors:  Shona Horter; Beverley Stringer; Jane Greig; Akhmet Amangeldiev; Mirzagaleb N Tillashaikhov; Nargiza Parpieva; Zinaida Tigay; Philipp du Cros
Journal:  BMC Infect Dis       Date:  2016-07-28       Impact factor: 3.090

10.  "When Treatment Is More Challenging than the Disease": A Qualitative Study of MDR-TB Patient Retention.

Authors:  Kalpita S Shringarpure; Petros Isaakidis; Karuna D Sagili; R K Baxi; Mrinalini Das; Amrita Daftary
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.